| Alkermes Inc. F4Q10 (Qtr End 03/31/10) Earnings Call Transcript Alkermes Inc. (ALKS)F4Q10 Earnings CallMay 13, 2010 4:30 pm ETComplete Story » seekingalpha.com |
Vivus's Obesity Drug Awaiting FDA Review: Expecting Positive Ruling Kaushik Paul submits:On July 15, 2010, the U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee is expected to review the marketing application of VIVUS Inc. (VVUS)’s Qnexa (formerly known as VI-0521), designed for the treatment of obesity.The Endocrinologic and Metabolic Drugs Advisory Committee is a panel of experts that reviews and evaluates data regarding the safety and effectiveness of marketed and investigational human drugs for use in the treatment of hormonal and metabolic disorders. The committee also provides the FDA with scientific and medical guidance to facilitate the marketing approval decisions of the drugs under review.Complete Story » seekingalpha.com |
Steps to Fight Ticks in the Yard While most people worry about tick bites after outdoor activities like camping, hiking and golf, the majority of bites happen close to home. online.wsj.com |
Sanofi Lines Up Genzyme Financing French drug maker Sanofi is lining up more financing as it contemplates raising its $18.5 billion bid for U.S. biotech Genzyme. online.wsj.com |
Practicing Patience at the Doctors' Office Of all the problems with the health-care system, one of the most vexing for patients is sitting in the doctor's waiting room. It's the health-care equivalent of being stuck on the tarmac in a crowded plane. online.wsj.com |